Covid-19 live updates: Pfizer, BioNTech tell FDA vaccine trial had favorable results in young children – The Washington Post

“We continue to work diligently to develop and study new ways that our investigational oral antiviral candidate could potentially lower the impact of COVID-19,” Mikael Dolsten, Pfizer’s chief scientific officer, said in a statement. “If successful, we believe this therapy could help stop the virus early — before it has had a chance to replicate extensively — potentially preventing symptomatic disease in those who have been exposed and inhibiting the onset of infection in others.”

Original News Source Link

Leave a Comment